Health
Study reports promising new monoclonal antibody against SARS-CoV-2’s spike protein – News-Medical.Net
An encouraging new study describes a promising new therapeutic antibody that shows potent neutralizing activity against SARS-CoV-2, the causative agent of COVID-19….
As the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), refuses to subside, the search for effective antivirals and therapeutics continues without respite. An encouraging paper published in the journal Nature Communicationson January 12, 2021, describes a promising new therapeutic antibody that potently neutralizes the virus.
SARS-CoV-2 has its own spike protein that interacts with the human angiotensin-converting enzyme 2 (ACE2)…
-
Noosa News8 hours agoHow Lily Steele-Park took her rapist to court and won
-
General22 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business13 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General24 hours agoQantas ‘contacted by potential cybercriminal’ after attack on data of up to 6 million customers